Intelligent Competitors

Summary

IQMDWDelisted Stock

USD 0 0.00 0.00%

Intelligent Medicine competes with Plexus Corp, FormFactor, Nike, Shoe Carnival, and NETGEAR; as well as few others. The company classifies itself under Financial Services sector and is part of Shell Companies industry. Analyzing Intelligent Medicine competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Intelligent Medicine to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Intelligent Medicine competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intelligent Medicine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
0.00	0	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0	0.00

Details

Intelligent Medicine Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Intelligent Medicine and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Intelligent and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Intelligent Medicine does not affect the price movement of the other competitor.

	PLXS	FORM	NKE	SCVL	NTGR	CTRN	ROST
PLXS		-0.56	-0.57	-0.64	0.87	0.56	-0.47	PLXS
FORM	-0.56		0.65	0.56	-0.62	-0.08	0.24	FORM
NKE	-0.57	0.65		0.74	-0.47	0.01	0.53	NKE
SCVL	-0.64	0.56	0.74		-0.49	-0.22	0.53	SCVL
NTGR	0.87	-0.62	-0.47	-0.49		0.65	-0.37	NTGR
CTRN	0.56	-0.08	0.01	-0.22	0.65		-0.36	CTRN
ROST	-0.47	0.24	0.53	0.53	-0.37	-0.36		ROST
	PLXS	FORM	NKE	SCVL	NTGR	CTRN	ROST

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

NTGR	+ 0.87	PLXS
SCVL	+ 0.74	NKE
NKE	+ 0.65	FORM
CTRN	+ 0.65	NTGR
CTRN	+ 0.56	PLXS
SCVL	+ 0.56	FORM

High negative correlations

SCVL	- 0.64	PLXS
NTGR	- 0.62	FORM
NKE	- 0.57	PLXS
FORM	- 0.56	PLXS
NTGR	- 0.49	SCVL
NTGR	- 0.47	NKE

Risk-Adjusted Indicators

There is a big difference between Intelligent Stock performing well and Intelligent Medicine Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Intelligent Medicine's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PLXS	1.40	0.17	0.17	0.22	1.22	(1.56)	3.38	(1.91)	12.92
FORM	2.30	(0.55)	0.00	(0.11)	0.00	0.00	4.53	(5.08)	19.85
NKE	1.16	(0.10)	0.00	(0.21)	0.00	0.00	2.37	(2.31)	13.61
SCVL	2.04	(0.49)	0.00	(0.13)	0.00	0.00	5.16	(4.39)	16.24
NTGR	2.29	0.55	0.29	0.57	1.53	(2.99)	5.28	(3.74)	34.93
CTRN	2.02	0.38	0.17	0.45	1.93	(2.51)	5.18	(2.97)	17.32
ROST	1.06	0.00	(0.05)	0.13	1.40	(1.04)	2.46	(2.62)	6.21

Unable to evaluate fundamental data of [PLXS, FORM, NKE, SCVL, NTGR, CTRN, ROST] at this time. Please try again later

All Fundamental Data

Intelligent Medicine Competitive Analysis

The better you understand Intelligent Medicine competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Intelligent Medicine's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Intelligent Medicine's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	IQMDW	PLXS	FORM	NKE	SCVL	NTGR	CTRN	ROST
	0.00 0 Intelligent	1.28 164.40 Plexus	1.91 40.06 FormFactor	0.55 78.77 Nike	0.45 33.76 Shoe	2.33 24.60 NETGEAR	0.35 19.95 Citi	0.01 154.87 Ross
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	Solid	Very Weak	Very Weak	Very Weak	Good	Solid	Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Dangerous	Very Low	Very Small	Very Low	Low	Low	Low	Very Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Fairly Valued	Under Valued	Over Valued	Under Valued	Under Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Buy	Buy	Buy	Strong Buy	Buy	Strong Buy	Strong Buy
Trade Advice (90 Days Macroaxis Advice)	Not Rated	Strong Buy	Sell	Strong Hold	Strong Sell	Buy	Buy	Cautious Hold
Current Ratio	N/A	1.43 X	3.15 X	2.64 X	2.84 X	2.51 X	1.13 X	1.95 X
Net Asset	214.03 M	3.15 B	1.11 B	38.11 B	1.04 B	847.14 M	518.72 M	14.3 B
Profit Margin	N/A	0.03 %	0.18 %	0.11 %	0.06 %	0.03 %	(0.03) %	0.1 %
EBITDA	(14.54 M)	158.41 M	82.76 M	7.16 B	125.22 M	(33.27 M)	3.41 M	2.97 B
Operating Margin	N/A	0.05 %	0.09 %	0.10 %	0.09 %	(0.02) %	(0.13) %	0.12 %
Current Valuation	N/A	4.39 B	2.79 B	119.08 B	1.2 B	345.55 M	344.51 M	52.77 B
Price To Book	N/A	3.36 X	3.25 X	8.41 X	1.44 X	1.29 X	1.26 X	9.76 X
Retained Earnings	(10.86 M)	1.82 B	51.33 M	965 M	714.65 M	(432.32 M)	319.07 M	3.55 B
Current Asset	N/A	1.43 B	56.7 M	15.03 B	370.08 M	821.14 M	222.29 M	2.37 B
Five Year Return	N/A	N/A	N/A	0.95 %	1.00 %	N/A	1.37 %	0.90 %
Beta	N/A	0.88	1.12	1.03	1.56	0.83	2.4	1.1
Number Of Employees	1	20 K	2.12 K	79.4 K	2.3 K	638	2.7 K	108 K
Shares Outstanding	N/A	27.09 M	77.45 M	1.19 B	27.17 M	28.77 M	8.62 M	331.76 M
Cash Flow From Operations	(866.9 K)	436.5 M	64.6 M	7.43 B	122.76 M	56.85 M	(9.58 M)	2.51 B
Annual Yield	N/A	N/A	N/A	0.02 %	0.02 %	N/A	N/A	0.01 %
Total Debt	165 K	279.59 M	48.15 M	11.95 B	354.34 M	41.57 M	234.65 M	5.75 B
Return On Equity	N/A	0.0881	0.15	0.38	0.13	0.0362	-0.15	0.43
Z Score	-0.3	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	0 X	48.70 X	12.33 X	9.35 X	21.50 X	19.13 X	16.45 X	14.53 X
Return On Asset	N/A	0.0363	0.0269	0.11	0.0587	-0.0463	-0.0386	0.11
Number Of Shares Shorted	N/A	511.82 K	2.59 M	24.89 M	2.76 M	891.37 K	1.13 M	4.03 M
Current Liabilities	N/A	650.44 M	16.06 M	5.36 B	87.93 M	315.77 M	95.66 M	1.6 B
Total Asset	214.03 M	3.15 B	1.11 B	38.11 B	1.04 B	847.14 M	518.72 M	14.3 B
Debt To Equity	N/A	0.45 %	0.07 %	0.80 %	0.65 %	0.05 %	1.85 %	1.38 %
Short Ratio	N/A	3.01 X	3.36 X	2.64 X	10.38 X	2.66 X	16.66 X	2.19 X
Target Price	N/A	153.2	53.56	90.86	49.0	22.0	23.0	168.77
Last Dividend Paid	N/A	N/A	N/A	1.48	N/A	N/A	N/A	N/A
Shares Owned By Institutions	N/A	99.85 %	97.64 %	81.82 %	72.28 %	85.09 %	86.70 %	91.81 %
Market Capitalization	N/A	4.45 B	3.1 B	116.61 B	917.38 M	707.74 M	172.48 M	51.38 B
Price To Earning	N/A	20.90 X	21.12 X	30.18 X	6.77 X	7.07 X	13.03 X	28.07 X
Price To Earnings To Growth	N/A	1.61 X	0.71 X	4.03 X	0.95 X	2.84 X	1.08 X	2.08 X
Price To Sales	N/A	1.12 X	4.18 X	2.33 X	0.74 X	1.04 X	0.23 X	2.44 X
Net Income	11.41 M	111.81 M	82.39 M	5.7 B	73.35 M	(104.77 M)	(11.98 M)	1.87 B
Earnings Per Share	N/A	4.01 X	1.73 X	3.49 X	2.72 X	0.67 X	(2.67) X	6.35 X
Shares Owned By Insiders	N/A	1.68 %	0.94 %	1.70 %	35.50 %	6.77 %	13.30 %	2.11 %
Revenue	N/A	3.96 B	663.1 M	51.36 B	1.18 B	740.84 M	747.94 M	20.38 B
Working Capital	(891.12 K)	833.86 M	442.69 M	14.79 B	353.46 M	483.63 M	55.2 M	3.21 B
Cash And Equivalents	69.33 K	276.61 M	251.59 M	7.44 B	47.52 M	233.2 M	27.91 M	3.91 B
Cash Per Share	0.01 X	9.98 X	3.26 X	7.59 X	1.73 X	8.07 X	3.42 X	11.42 X
Gross Profit	N/A	347.23 M	308.26 M	21.48 B	468.16 M	250.55 M	310.99 M	5.68 B
Day Typical Price	0.003	164.12	40.19	78.66	33.86	24.38	19.97	154.82
Accumulation Distribution	N/A	0.014	0.0214	0.0145	0.0213	0.0312	0.0488	0.0114
Market Facilitation Index	N/A	2.32	0.87	1.15	0.73	0.77	1.0	1.78
Daily Balance Of Power	0.0	0.8922	0.8621	0.3739	0.2055	0.7273	(0.07)	(0.01)
Period Momentum Indicator	N/A	2.07	0.75	0.43	0.15	0.56	(0.07)	(0.02)
Rate Of Daily Change	1.0	1.01	1.02	1.01	1.0	1.02	1.0	1.0
Day Median Price	0.003	163.98	40.25	78.61	33.92	24.28	19.98	154.8
Price Action Indicator	N/A	1.46	0.18	0.38	(0.08)	0.61	(0.07)	0.06
Coefficient Of Variation	(3,500)	509.99	(1,340)	(3,245)	(1,204)	615.6	515.94	2282.09
Mean Deviation	10.62	1.4	2.3	1.16	2.04	2.29	2.02	1.06
Jensen Alpha	0.0911	0.1696	(0.55)	(0.10)	(0.49)	0.551	0.3825	0.0023
Total Risk Alpha	(4.01)	0.0509	(0.81)	(0.35)	(0.71)	(0.03)	0.0652	(0.19)
Sortino Ratio	N/A	0.1671	N/A	N/A	N/A	0.2904	0.1706	(0.05)
Downside Variance	N/A	2.65	N/A	N/A	N/A	4.0	5.61	2.24
Standard Deviation	20.47	2.09	3.33	1.74	2.78	4.42	2.8	1.45
Kurtosis	8.48	6.96	3.27	5.73	1.49	33.33	2.54	1.48
Potential Upside	37.5	3.38	4.53	2.37	5.16	5.28	5.18	2.46
Treynor Ratio	0.1107	0.2216	(0.11)	(0.21)	(0.13)	0.5741	0.4545	0.1334
Maximum Drawdown	166.47	12.92	19.85	13.61	16.24	34.93	17.32	6.21
Variance	419.12	4.37	11.07	3.02	7.75	19.57	7.81	2.1
Market Risk Adjusted Performance	0.1207	0.2316	(0.10)	(0.20)	(0.12)	0.5841	0.4645	0.1434
Risk Adjusted Performance	(0.01)	0.1562	(0.05)	(0.02)	(0.06)	0.1324	0.1554	0.0382
Skewness	0.1275	1.7	(1.10)	0.0537	0.1401	5.0	0.2562	0.182
Semi Deviation	N/A	1.22	N/A	N/A	N/A	1.53	1.93	1.4
Information Ratio	(0.04)	0.1302	(0.12)	(0.11)	(0.13)	0.1313	0.1446	(0.05)
Value At Risk	(22.22)	(1.91)	(5.08)	(2.31)	(4.39)	(3.74)	(2.97)	(2.62)
Expected Short fall	N/A	(1.56)	N/A	N/A	N/A	(2.99)	(2.51)	(1.04)
Downside Deviation	N/A	1.63	N/A	N/A	N/A	2.0	2.37	1.5
Semi Variance	N/A	1.49	N/A	N/A	N/A	2.35	3.74	1.96

Intelligent Medicine Competition Performance Charts

Five steps to successful analysis of Intelligent Medicine Competition

Intelligent Medicine's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Intelligent Medicine in relation to its competition. Intelligent Medicine's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Intelligent Medicine in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Intelligent Medicine's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Intelligent Medicine, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Intelligent Medicine position

In addition to having Intelligent Medicine in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipping Containers Thematic Idea Now

Shipping Containers

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 16 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.

View All Next

Launch

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Intelligent Stock

If you are still planning to invest in Intelligent Medicine check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intelligent Medicine's history and understand the potential risks before investing.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC